Expert: With New COVID-19 Vaccine Approvals, Pharmacists Should Remain Vigilant
Allison Hill, PharmD, RPh, emphasized that pharmacists must stay updated on ACIP and state-level guidance following HHS’s changes to COVID-19…
New Nanoparticle Treatment Shows Promise for Preventing Rheumatoid Arthritis Flares
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
Biedermann Medtech Group annuncia la trasformazione dell'approccio al mercato della spina dorsale e il nuovo modello aziendale negli Stati Uniti
MIAMI–(BUSINESS WIRE)–Il Biedermann Medtech Group, il prominente innovatore nei sistemi implantari per la colonna vertebrale e le estremità e nelle…
Le Biedermann Medtech Group annonce une transformation de son approche du marché américain de la chirurgie de la colonne vertébrale et un nouveau modèle économique
MIAMI–(BUSINESS WIRE)–Le Biedermann Medtech Group, important innovateur dans les systèmes d’implants et les solutions procédurales de nouvelle génération pour la…
Biedermann Medtech Group kündigt Umgestaltung ihres Ansatzes für den US-amerikanischen Wirbelsäulenmarkt und neues Geschäftsmodell an
MIAMI–(BUSINESS WIRE)–Die Biedermann Medtech Group, ein führender Innovator im Bereich der Implantatsysteme und Verfahrenslösungen der nächsten Generation für Wirbelsäule und…
Pneumococcal Positivity Associated With More Severe COVID-19 Outcomes
Patients with severe COVID-19 who tested positive for Streptococcus pneumoniae had higher mortality rates.
Aquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk
August 28, 2025, AquaStar (USA) Corp of Seattle, WA is recalling approximately 26,460 packages of Cocktail Shrimp 6oz (see photo),…
Antimicrobial Drugs Advisory Committee (formerly known as the Anti-Infective Drugs Advisory Committee) Roster
This page contains the AMDAC roster, which lists the current members and the current number of vacancies for the committee
FDA Approves REMS Modification for Sparsentan in IgA Nephropathy
The FDA updated sparsentan’s REMS, easing monitoring requirements, enhancing treatment access for IgA nephropathy patients, and supporting kidney function preservation.
